Glucuronidation converts clopidogrel to a strong time-dependent inhibitor of CYP2C8: a phase II metabolite as a perpetrator of drug-drug interactions.

A Tornio, AM Filppula, O Kailari, M Neuvonen, TH Nyrönen, T Tapaninen, PJ Neuvonen, Mikko Niemi, JT Backman

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

94 Citeringar (Scopus)
OriginalspråkEngelska
TidskriftClinical Pharmacology and Therapeutics
DOI
StatusPublicerad - okt 2014
MoE-publikationstypA1 Tidskriftsartikel-refererad

Citera det här